Wilkinson Walsh Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

WASHINGTON –Wilkinson Walsh enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Wilkinson Walsh Announces Three Promotions

WASHINGTON — Wilkinson Walsh today announced three promotions. Kieran Gostin and Ralia Polechronis were elected to the partnership, and Andrew Croner was promoted to counsel. The promotions took effect on June 1. “Kieran, Ralia, and Andrew have each in their own ways played an integral role in many of the firm’s successes, from inside the courtroom to mentoring fellow colleagues,” said founding partner Alex Walsh. “We are truly fortunate to have them in the Wilkinson Walsh family. Their well-deserved promotions are a testament to their value to the firm.” An experienced defense attorney, Kieran has represented government and corporate clients in products liability, antitrust, data breach, copyright, national security, First Amendment, Privacy Act, Administrative Procedure Act, and other complex civil litigation matters. Kieran recently helped lead a trial team that won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit (Farar et al. v. Bayer) …

Wilkinson Walsh Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

WASHINGTON – Wilkinson Walsh is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Walsh’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Walsh won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Walsh, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Walsh, led by Kosta Stojilkovic …